OSWEGO, N.Y. — Oswego Health says it has purchased the cobas 5800 System, which it describes as a fully automated molecular laboratory instrument.
It offers a flexible PCR testing product to enable “accurate and reliable” diagnosis of infectious diseases, including chlamydia, gonorrhea, COVID-19, and HPV testing, Oswego Health said in its Wednesday announcement.
The system is built to offer a fully automated workflow and offers an expanded onboard capacity, allowing labs to test multiple assays simultaneously. It takes about 2.5 hours to produce the first 24 results. With 24 more results ready every 60 minutes thereafter, cobas 5800 has the capability of delivering up to 144 results in 8 hours.
(Sponsored)
Avoid the Employment Law Mistakes that Threaten Your New Business
Amid the excitement and uncertainty that accompany the opening of a new business, entrepreneurs often overlook basic employment law requirements that can cost them dearly. These include how they classify
Fraud Contingencies Plans Are Essential
Your business likely has a disaster recovery plan in place—procedures for handling fires, natural disasters or other crises that could disrupt operations or endanger lives. While a fraud contingency plan
Oswego Health says it’s the fourth health-care system in the country to purchase the cobas 5800 System.
